Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000873 · ClinicalTrials.gov registry record · NA
A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
NCT00000873: Completed NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00000873 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 2,400 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000873, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
Study Summary
This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants. HIV disease in infants often leads to nutritional deficiencies. Providing increased nutrition early in their lives may help the quality of life of children who contract HIV from their mothers.
Interventions
- DRUG Infant Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Est. Completion | 2005-09 |
| Phase | NA |
What the finished NCT00000873 record still lists
NCT00000873 is an interventional study that assigns participants to a tested intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% higher).
The record links to 0 conditions, and to 1 intervention - of which Infant Formula is the first listed.
NCT00000873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000873 about?
NCT00000873 is a clinical study titled "A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants". This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants. HIV disease in infants o...
What is the current status of trial NCT00000873?
This trial is currently completed. It is a NA study. The enrollment target is 2,400 participants. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00000873?
The interventions under investigation include: Infant Formula (DRUG).
Who is sponsoring clinical trial NCT00000873?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000873's enrollment target sits among peer trials
2,400 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage